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The latency-associated transcripts (LATs) of herpes simplex virus type-1 (HSV-1) are the only viral RNAs accumulating during latent
infections in the sensory ganglia of the peripheral nervous system. The major form of LAT that accumulates in latently infected neurons is a 2 kb
intron, spliced from a much less abundant 8.3 primary transcript. The spliced exon mRNA has been hard to detect. However, in this study, we have
examined the spliced exon RNA in productively infected cells using ribonuclease protection (RPA), and quantitative RT-PCR (q-PCR) assays. We
were able to detect the LAT exon RNA in productively infected SY5Y cells (a human neuronal cell line). The level of the LAT exon RNA was
found to be approximately 5% that of the 2 kb intron RNA and thus is likely to be relatively unstable. Quantitative RT-PCR (q-PCR) assays were
used to examine the LAT exon RNA and its properties. They confirmed that the LAT exon mRNA is present at a very low level in productively
infected cells, compared to the levels of other viral transcripts. Furthermore, experiments showed that the LAT exon mRNA is expressed as a true
late gene, and appears to be polyadenylated. In SY5Y cells, in contrast to most late viral transcripts, the LAT exon RNA was found to be mainly
nuclear localized during the late stage of a productive infection. Interestingly, more LAT exon RNA was found in the cytoplasm in differentiated
compared to undifferentiated SY5Y cells, suggesting the nucleocytoplasmic distribution of the LAT exon RNA and its related function may be
influenced by the differentiation state of cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: HSV-1; LAT; ExonIntroduction
Herpes simplex virus type-1 is a neurotropic virus and
establishes life long latent infections in the sensory ganglia of the
peripheral nervous system (for review see (Wagner and Bloom,
1997). During latency, the latency-associated transcripts (LATs)
are the only abundantly transcribed RNA (for review see Fraser
et al., 1992). The LAT region has been implicated to play a role in
promoting efficient establishment of latency and viral reactiva-
tion (for review see Kent et al., 2003). The major form of LAT is
a 2 kb intron, which is spliced from an 8.3 primary transcript
(Farrell et al., 1991). However, the spliced 6.3 kb exon RNA has⁎ Corresponding author. Fax: +1 215 898 3849.
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doi:10.1016/j.virol.2006.07.033been hard to detect by any method. Previous studies using
Northern blot analysis and ribonuclease protection assay failed
to detect the spliced LAT exon RNA (Devi-Rao et al., 1991;
Dobson et al., 1989). It has been speculated that that the LAT
exon is either expressed at a very low level or undergoes rapid
degradation in tissue. Using sensitive RT-PCR assays, a number
of groups have been able to detect the spliced LAT exon in
productively infected cells (Alvira et al., 1999; Krummenacher
et al., 1997). However, a complete characterization of the LAT
exon RNA remains to be performed.
Several lines of evidence recently indicate that the LAT exon
region may play a role in the life cycle of HSV-1. The 5′1.5 kb
region of LAT has been implicated in promoting cell survival
through an anti-apoptotic mechanism (Ahmed et al., 2002; Jin
et al., 2003; Perng et al., 2000). This region is also known to be
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(Lokensgard et al., 1997). In addition to its enhancer activity,
the LAT exon 1 has also been reported to function as a region
responsible for keeping the LAT promoter active during latency
(Berthomme et al., 2001).
It is unknown whether protein translation from the LAT
exon mRNA occurs during infection. Although it has been
suggested that large protein products translated from the first
1.5 kb LAT are unlikely (Drolet et al., 1998), polypeptides
such as ORF P may be translated from the LAT exon II region
under certain circumstances (Bruni and Roizman, 1996). In
addition, previous work has shown that a transgene inserted in
the exon 1 region of the LAT was translated in some CNS
neurons in mice during latency (Zhu et al., 2000), suggesting
that protein translation in the exon 1 region is possible,
especially in certain types of neurons during latency. Alter-
natively, the LAT exon transcript may function as a regulatory
RNA (Inman et al., 2001), since it is transcribed from the
opposite strand of viral immediate early gene ICP0, and it has
been speculated that it may down-regulate the expression of
ICP0 by an antisense mechanism (Stevens et al., 1987). In fact,
LAT has been shown to inhibit the transactivating activity of
ICP0 in transient transfection assays (Farrell et al., 1991).
Furthermore, several reports suggest that LAT suppresses viral
replication and reduces viral mRNA levels (Chen et al., 1997;
Mador et al., 1998). Recent studies performed in our lab
indicate that the exon 1 of the LAT gene encodes an miRNA
that plays an active role in regulating apoptosis in the infected
cell (Gupta et al., 2006).
In the present study, we have examined the expression of the
LAT exon mRNA in productively infected cells. Using a
ribonuclease protection assay, we quantified the LATexon RNA
in productively infected cells. It was found that the LAT spliced
exon RNA was present at a level that is approximately 5% of
that of the 2 kb LAT intron on a molar basis. The LAT exon
mRNA appeared to be mainly retained in the nucleus of
productively infected cells during the late stage of an infection.
Interestingly, the LAT mRNA appeared to favor a more
cytoplasm distribution in differentiated compared to un-
differentiated SY5Y cells, indicating that the distribution ofFig. 1. Detection of LATexon and intron RNA in productively infected SY5Y cells by
extracted 16 h post-infection. 32P-labeled riboprobes for RPAwere generated by in v
Protected fragments were resolved by 6% Urea-TBE polyacrylamide gel electrophore
LAT exon probe; (2) 10 μg yeast RNA; (3) 20 μg mock SY5Y RNA; (4) 40 μg infect
Lane labels in panel B are: (1) LAT intron probe; (2) 10 μg yeast RNA; (3) 40 μg infec
(6) 20 μg mock SY5Y RNA.the LAT exon RNA and its related function may be influenced
by the differentiation state of the infected cell.
Results
Detection of LAT exon RNA by RPA
In an attempt to detect LATexon RNA, Northern blot analysis
was first performed. However, we were unable to detect any
specific signals associated with the LAT exon RNA (data not
shown). Thus we employed an alternative approach, and
examined the presence of the LAT exon RNA by a more
sensitive method—ribonuclease protection assay (RPA). To
allow the detection and quantitation of the LAT exon RNA, a
plasmid (Lex2) encoding a 245 bp fragment of the LAT exon I–
exon II junction was constructed as described in Materials and
methods and used for in vitro transcription of RNA antisense to
the LAT exon. To detect the 2 kb LAT intron RNA, a fragment
consisting a 265 bpHSV-1DNA (HSV-1 nt 119382 to nt 119647)
was cloned to generate the plasmid Dex1 and used for in vitro
transcription of RNA antisense to the LAT intron. Control
plasmids were also made in which the inserts were cloned in the
opposite orientation, and sense RNAs to the LAT were made
following in vitro transcription under the T7 promoter.
SY5Y cells were infected with HSV-1 strain F and total RNA
was isolated 16 h post-infection. RPA assays were performed on
the total RNAwith the LAT exon and intron probes. The results
are shown in Fig. 1. A protected fragment of 245 bases,
corresponding to the spliced LAT exon, was seen with RNA
from infected SY5Y cells, but not in mock infected SY5Y cells
or with yeast control RNA (Fig. 1A). The 182 nt band
representing the LAT intron was readily detected in infected
SY5Y cell RNA (Fig. 1B). Both LAT exon and intron signals
intensified with increasing amounts of RNA from infected cells.
However, the intensity of the LAT exon band appeared to be
much weaker than that of the LAT intron when equal amounts of
probes were included in all hybridization reactions. A
quantification on the intensity of bands after being adjusted
for the probe length suggested that the level of the LAT exon
was approximately 5% of that of the LAT intron, and therefore,RPA. SY5Y cells were infected with HSV-1 strain F (moi=3) and total RNAwas
itro translation of linear plasmid templates under the control of the T7 promoter.
sis and gel images analyzed by a phosphoimager. Lane labels in panel A are: (1)
ed SY5Y RNA; (5) 20 μg infected SY5Y RNA; (6) 10 μg infected SY5Y RNA.
ted SY5Y RNA; (4) 20 μg infected SY5Y RNA; (5) 10 μg infected SY5Y RNA;
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about 20:1 at the late stage of an infection. In addition to the
LAT exon and intron bands, a few other protected fragments
were also detected by the RPA assay. Those are possibly
transcripts extending from the LAT exon 1 into the LAT intron,
as previously reported by others (Devi-Rao et al., 1991; Dobson
et al., 1989). Control RPA reactions were also performed with
sense probes, and no signal were detected (data not shown).
The LAT exon RNA is retained in the nucleus of SY5Y cells at
the late stage of a productive infection
To further characterize the LAT exon RNA in a more
sensitive and quantitative way, a real-time PCR assay with
SYBR green was developed to measure the amount of LAT
exon present in infected cells. To confirm the PCR product
specificity, dissociation curve analysis was performed following
each PCR run. We also tested RNA from uninfected cell or cells
infected with a LAT null mutant (17DeltaPst), and no PCR
product was found (data not shown). For comparison, the
presence of several other viral transcripts, in the same cDNA
sample was measured at the same time by real-time PCR.
Standard curves (Fig. 2) for each gene were established by
amplifying serially diluted plasmid DNA or viral DNA with
respective primers. Values obtained for each experimental
sample were determined based on the standard curves.
The nuclear-cytoplasmic distribution of the LAT exon RNA
was examined using SY5Y cells infected with HSV-1 strain F.
Cytoplasmic and nuclear RNAs were isolated 16 h post-
infection. The separation of the nuclear and cytoplasmic RNA
was confirmed by the absence of ribosomal RNA precursors, as
well as predominant presence of 18S and 28S RNA in
cytoplasmic fractions following RNA gel electrophoresis. The
nuclear/cytoplasmic ratio for each viral transcript was deter-
mined and calculated as follows. Briefly, upon harvesting theFig. 2. Standard curves for real-time PCR with different primer sets. The
standard curve was generated by PCR amplifying serial dilutions of viral DNA
or plasmid DNA in 100 ng/μl mouse genomic DNA (see Materials and
methods). Each sample was measured in triplicates. Sequences of the primers
and probes are shown in Table 1. For all real-time PCR runs with SYBR green,
dissociation curve analysis was performed to confirm the specificity of the
product amplified.nuclear and the cytoplasmic RNA from infected cells, a ratio
between the yield of the nuclear RNA and that of the
cytoplasmic RNA was obtained (R). Overall in these experi-
ments, the yield of nuclear RNA was about 10% of that of the
cytoplasmic RNA for infected SY5Y cells. One microgram of
nuclear or cytoplasmic RNA was reverse transcribed and
subjected to real-time PCR analysis to determine the amount of
each viral transcript present. The value obtained for the nuclear
RNAwas later adjusted based on the RNAyield ratio (× R) and
the final ratio between the nuclear and cytoplasmic fractions
was therefore presented as a per cell basis. The nuclear-
cytoplasmic distribution of the LAT exon RNA as well as
several other late viral transcripts is shown in Fig. 3. Transcripts
of the late viral genes gC and VP16 were predominantly present
in the cytoplasm (70–80%) during the late phase of infection,
suggesting an efficient transport of these RNAs. In contrast,
spliced viral RNA transcripts for UL15 and the LAT exon were
largely retained in the nucleus. In the case of LAT exon, nearly
90% of total LAT exon RNAwas present in the nuclear fraction.
These data suggest that these transcripts may not be exported
efficiently out of the nucleus during the late stage of an
infection. The nuclear predominance for the spliced viral
transcripts was not surprising. Nuclear retention of transcripts
from spliced HSV-1 genes, UL15 and ICP0, has been
previously reported (Phelan et al., 1996). Furthermore, it has
been shown that the nuclear export of intron-containing and
intronless HSV-1 transcripts is dependent on different mechan-
isms (Sandri-Goldin, 2001).
Because the LAT exon RNA was predominately in the
nucleus, we next compared the nuclear LAT exon level with
other late viral transcripts using real-time PCR (Fig. 4). Results
are presented as Ct values (cycle threshold), which are the
number of PCR cycles needed to reach a level that is above an
arbitrary set threshold of detection. Therefore, a higher Ct value
for a particular transcript represents a lower RNA level. In
addition, our real-time PCR assays were optimized so that the
sensitivity of each set of viral gene primers was similar (Fig. 2).
Therefore, a direct comparison could be made among the results
from different genes based on the Ct value. As shown in Fig. 4,
the Ct value for the LAT exon was significantly higher than
those of the other late viral genes examined, throughout the time
course of a productive infection. The low level presence of the
LAT exon RNA shown by the real-time PCR assay is in good
agreement with the results from the RPA experiments.
As shown in Fig. 4, Ct values for the LAT exon decreased
during the course of infection with the lowest value reached at
16 h post-infection, a trend similar to that of another true late
gene—gC. In contrast, UL15 and VP16 showed lowest Ct
values at 10 h post-infection, confirming the kinetics of these
genes as being in the early–late category. The decrease in Ct
values of these late genes could be reversed by pre-treating the
cells with a DNA synthesis inhibitor PAA (Fig. 4).
The LAT exon is polyadenylated
It has been speculated previously that the consensus
sequence AATAAA at ∼8.3 kb downstream of the LAT
Fig. 3. The HSV-1 LAT exon is retained in the nucleus of productively infected
SY5Y cells at the late stage of infection. SY5Y cells were infected with HSV-1
strain F at moi of 3. Cytoplasmic and nuclear RNAs were isolated 16 h post-
infection. The amount of each viral transcript was measured by quantitative
PCR, and values were determined based on standard curves. The nuclear/
cytoplasmic ratio of each viral transcript is presented on a per cell basis. Error
bars represent the standard deviation of at least 5 independent experiments.
Fig. 5. The LAT exon RNA is polyadenylated. SY5Y cells were infected with
HSV-1 strain F (moi=3) and harvested 16 h post-infection. Total RNA was
extracted with Trizol reagent and polyadenylated RNA fractionated from the
total RNA with a PolyA Purist kit. One microgram of total RNA or poly(A)
RNAwas subjected to RT-PCR analysis. The real-time PCR Ct values for viral
transcripts, LAT exon and VP16, and 18S ribosomal RNA were obtained. The
differences in Ct values (delta Ct) between the total RNA fraction and the poly
(A) fraction are presented.
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the LAT exon mRNA (Dobson et al., 1989). However, those
earlier studies have failed to detect any distinctive mRNA
species at the predicted size in poly(A) enriched RNA fractions.
Thus we set out to investigate the poly(A) status of the spliced
LATexon RNA. Following isolation of total RNA from infected
SY5Y cells, polyadenylated RNA was fractionated from the
total RNA using a Poly A Purist system (Ambion). One micro-
gram of total, or poly(A), RNA was reverse transcribed into
cDNA and real-time PCR analysis performed. Differences in
the real-time PCR Ct values between the total RNA and poly(A)
RNA fractions are shown in Fig. 5. Similar to the well
characterized polyadenylated viral transcript VP16, LAT exon
RNAwas found to be concentrated in the poly(A) fraction as the
Ct value for the total RNA fraction was higher than the Ct value
for the poly(A) fraction. In contrast, the 18S ribosomal RNA,Fig. 4. Accumulation of viral transcripts in the nucleus of SY5Y cells during a
productively infection. SY5Y cells were infected with HSV-1 strain F (moi=3)
and cytoplasmic and nuclear RNAs were isolated at various times post-infection.
The amount of each viral transcript was measured by quantitative RT-PCR. The
average Ct value for each transcript, at 5, 10, and 16 h post-infection, is shown.
Error bars represent the standard deviation of at least four independent
experiments.which is known to be non-polyadenylated, showed a lower Ct
value in the total RNA fraction compared to that in the poly(A)
fraction.
This experiment provides direct evidence that the spliced
LAT exon RNA is polyadenylated. However, these results did
not answer the question whether the consensus polyadenylation
signal (AATAAA) 8.3 kb downstream of the LAT transcription
initiation site is being utilized. Studies have shown that nearly
30% of all mRNA 3′ ends use non-consensus poly(A) signals,
and furthermore, the use of more than one polyA sites for any
particular mRNA is far more common than previously thought
(Beaudoing et al., 2000).
The distribution of the LAT exon RNA is more cytoplasmic in
differentiated SY5Y cells
The SY5Y cells represent an ideal system to study HSV
infections as these cells can undergo physiological changes
towards terminally differentiated mature neuron cell types. It
displays many characteristics of sympathetic neurons, and can
be differentiated into a ganglion-like phenotype in response to
agents such as retinoic acid. In the present study, we observed
that following 5 days of retinoic acid (RA) treatment the ma-
jority of the SY5Y cells appeared to be more neuronal, with
more elongated neurites and fewer branches from the cell
body, and a 50% increase of the cell doubling time. We
examined the nuclear–cytoplasmic distribution of LAT exon
RNA in these differentiated SY5Y cells. Undifferentiated
SY5Y cells were grown in a medium containing 10 μm
retinoic acid for 5 days prior to infection and incubated in RA-
containing medium throughout the infection. Cells were
harvested 16 h post-infection, fractionated into nuclear and
cytoplasmic RNA, and analyzed for the presence of spliced
LAT exon RNA and several other viral transcripts. As shown
in Fig. 6, the nuclear to cytoplasmic ratio of the LAT RNA
decreased significantly in differentiated SY5Y cells compared
to that in undifferentiated cells. Our real-time PCR data
indicated that while the nuclear LAT exon level remained
Fig. 6. The nucleocytoplasmic distribution of LAT exon RNA in differentiated
SY5Y cells. SY5Y cells were differentiated in medium containing 10 μM
retinoic acid for 5 days and then infected with HSV-1 strain F (moi=3).
Cytoplasmic and nuclear RNAs were isolated 16 h post-infection. The amount
of each viral transcript was measured by quantitative RT-PCR. The nuclear/
cytoplasmic ratio for each viral transcript is presented on a per cell basis. Error
bars represent the standard deviation of at least three independent experiments.
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there was an increase of LAT exon in the cytoplasm of
differentiated SY5Y cells. In contrast, the nuclear–cytoplasmic
distributions of other viral transcripts, such as VP16, gC, and
UL15, were not affected by the cell differentiation as shown in
Fig. 6. These data suggest that the nuclear-cytoplasmic
distribution of LAT exon RNA specifically is influenced by
the differentiation state of cells.
We also examined the expression and distribution of LAT
exon RNA in HeLa cells, a human cervical epithelial cell line
(data not shown). The distribution of the LAT exon RNA
appeared to be more cytoplasmic in HeLa cells, with nearly
70% of the LAT exon RNA found in the cytoplasm. However,
the overall level of the LAT exon was found to be about 10-fold
lower in HeLa cells than that in SY5Y cells. This is not
surprising since the LAT promoter has been shown to possess
neuronal specificity (Zwaagstra et al., 1990). Nevertheless,
these results strongly suggested that the nucleocytoplasmic
distribution of the LATexon RNA appeared to dependent on the
differentiated state of cells.
Discussion
It is well known that the 2 kb LAT is a stable intron, spliced
from a large precursor (mLAT) (Farrell et al., 1991). Several
groups have attempted to identify the spliced LATexon RNA by
Northern blot or RPAwithout a success (Devi-Rao et al., 1991;
Dobson et al., 1989). Since the LAT intron and exon are
transcribed at the same rate and the LAT intron RNA is readily
detectable, we hypothesize that the LAT exon RNA is much less
stable. It has been reported that the LAT intron has a measured
half life of 24 h in undifferentiated SY5Y cells (Thomas et al.,
2002). Furthermore, it is known that the LAT exon and intron
are transcribed in a 1:1 ratio because they are derived from a
common precursor RNA. Based on these facts, we have
calculated the half life of the LAT exon using the assumptions
and last equation described below.Mathematical calculation of the half life of the exon transcript
For a LATmolecule, the fraction remaining at any given time
point t can be calculated as A0e
−kt, where A0 is the initial
amount and equals 1 unit at time zero, and K is the decay
constant. The decay constant K can be expressed as K= ln(2) /T
half life (Ross, 1995). With this information the decay constant of
the LAT intron Kintron=0.029/hour.
We then estimated the decay constant of the LAT exon Kexon
using Kintron and the molar ratio between the LAT exon and
intron at the same time t (16 h post-infection). It is known that
the LAT exon and intron are transcribed in a 1:1 ratio because
they are derived from a common precursor RNA. First we
assume for simplicity that the transcription of LAT is at a
constant rate, and all the RNA molecules are made in a
consecutive manner in a total number of n. Secondly, we assume
that the decay of the LAT exon and intron is a first-order process
(similar to a radioactive decay). For a LAT molecule, as
mentioned before the fraction remaining at any given time point
ti can be calculated as A=A0e
− kti, where A0 is the initial amount
and equals 1 unit at time zero, K is the decay constant and ti= t−
(t /n)iwith i a consecutive number (i=0, 1, 2,…, n−2, n−1). We
can also describe ti as the time passed from RNA synthesis to the
time of digestion, in other words, the time of decay.
At the time of digestion, the activities of all RNAs can be
summarized as
A ¼ A0 þ A1 þ A2 þ N þ An2 þ An1 ¼
Xn1
i¼0
Ai ð1Þ
using the half life equation, we get
A ¼
Xn1
i¼0
ekti ¼
Xn1
i¼0
ekðtðt=nÞiÞ ¼
Xn1
i¼0
eðkt=nÞi
ekt
ð2Þ
From Eqs. (1) and (2) we get:
ekt
Xn1
i¼0
Ai ¼
Xn1
i¼0
eðkt=nÞi ð3Þ
From Eq. (3) by multiply every side by ekt/n we get:
ekt=nekt
Xn1
i¼0
Ai ¼
Xn1
i¼0
eðkt=nÞðiþ1Þ ð4Þ
If we subtract each side of Eq. (4) from each side of Eq. (3), we
get:
ekt
Xn1
i¼0
Ai  ekt=nekt
Xn1
i¼0
Ai ¼
Xn1
i¼0
eðkt=nÞi 
Xn1
i¼0
eðkt=nÞðiþ1Þ
which is equal to:
ðekt  ekt=nektÞ
Xn1
i¼0
Ai ¼ 1 ekt
Then
Xn1
i¼0
Ai ¼ 1 e
kt
ekt  eðkt=nÞekt ¼
ektð1 ektÞ
1 eðkt=nÞ ¼ A
If the approximate molar ratio R between the LAT exon and
intron at known time t can be experimental verified, it is
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above described equation solving Aintron=Aexon R, where R
indicates the above-mentioned ratio. Therefore, the following
equation represents the relationship between the LAT exon
and the LAT intron in the number of molecules present at
16 h post-infection: e−kintron
t(1− e−kintront) / (1− ekintront/n)=
Re−kexon
t(1−ekexon t) / (1−ekexon t/n).
Our RPA experiments indicated an approximate molar ratio
of 1:20 between the LAT exon and intron at 16 h post-infection.
Thus, if we assume the LAT transcription starts 4 h post-
infection (time zero), and the RNAwas harvested at 16 h post-
infection, the time period t would equal to 12 h. Therefore
solving the equation Aintron=20*Aexon we calculated that the
decay constant for the exon to be near 2/hour, and the half life of
the LAT exon to be slightly over 20 min. It is important to
emphasize that our calculation is based on certain idealized
assumptions, and in cells RNA transcription and decay would
not completely follow these simplified processes. Nevertheless,
the result suggests that it is highly likely that the LATexon RNA
belongs to the category of many unstable RNAs. The short half
life of the full length LAT exon RNA in productively infected
cells suggests that either viral factors or sequences downstream
from the LAT splice junction are important in determining the
half life of the LAT exon RNA.
RNA stability plays a major role in modulating gene
expression in mammalian cells. In cells the control of gene
expression can be achieved by regulating the rate of mRNA
degradation. There are a number of determinants of mRNA
stability, such as poly(A) tails, 3′ and 5′ UTR sequences,
cellular factors binding to mRNA (Ross, 1995). Our results
suggest that the LAT exon RNA is likely to be relatively
unstable. It remains to be determined if there is a functional
significance for this instability. Several HSV-1 transcripts have
been reported to have half life of several hours (Henley and
Weir, 1991). It is difficult to compare the apparent instability of
the LAT exon with the half life of other HSV mRNAs or other
unstable cellular RNAs, such as cMyc, because these mRNAs
are efficiently exported to the cytoplasm and degradation
appears to occur in a translation dependent manner. However,
our study suggests that the LAT exon is largely retained in the
nucleus and RNA turnover in the nucleus is not as well
understood as RNA decay in the cytoplasm. It has been
assumed that the nuclear “junk” RNAs, such as intronic
sequences, are degraded after splicing because they are not
capped, polyadenylated, or bound by export proteins. That is,
they are “free” RNAs that are not associated with RNPs formed
by the Cap binding protein complex, polyA binding protein
(PABP), and export adaptor proteins. Since the LAT exon is
capped and polyadenylated, CBP and PABP will be bound to
protect the 5′ and 3′ ends. The fact that it is largely nuclear
localized suggests that other factors such as export adaptor
proteins such as UAP56 and Aly/REF, as well as other exon
junction proteins (EJC) are not bound. Recently, Gupta et al.
(2006) have shown that an miRNA is encoded in the exon RNA
of the LAT gene and that this may be the mechanism through
which the LAT exon RNA exerts its anti-apoptotic effect. Since
precursors for miRNA need to be processed in the nucleus bythe RNase III enzyme Drosha, therefore the instability of the
LAT exon may be a consequence of its processing into an
miRNA. It is also possible that the majority of the LAT exon is
transported to the cytoplasm efficiently but is then rapidly
degraded. However, there is no evidence to support this
mechanism.
The functional significance of the LAT exon RNA distribu-
tion is unclear. It is well known that mRNA has to be actively
transported to the cytoplasm from the nucleus in order to gain
access to translation machinery and to be translated into
proteins, even though translation in the nucleus has been
recently reported (Iborra et al., 2004). Our results presented here
and previous work by others (Phelan et al., 1996) showed that
most late viral transcripts were efficiently exported to the
cytoplasm during the late stage of infection when the gene
products from those late transcripts were made. Our findings
that the LAT exon RNA was mainly nuclear localized in
undifferentiated SY5Y cells and present at a level significantly
lower than that of other viral transcripts, suggest that the LAT
exon may not be efficiently translated in those cells. The finding
that LAT exon RNA in differentiated SY5Y cells appeared to be
more cytoplasmic was interesting given that LAT is expressed in
latently infected neurons. Changes in the nuclear-cytoplasmic
distribution of the LAT exon could be due to alternations of
either RNA export machineries, or RNA stability in the nucleus
or cytoplasm. Interestingly, only the LAT exon distribution was
altered upon the differentiation, suggesting that factors regulat-
ing the nucleocytoplasmic distribution of LAT exon RNA
maybe different from those for other viral transcripts.
Although the LAT region has been extensively studied for
over two decades, no protein products have been identified for
the LAT gene. There is an emerging notion that LAT could
function as a regulatory RNA. A number of regulatory RNAs of
varying length have been reported (Erdmann et al., 2001a).
These RNAs have no long open reading frames, are synthesized
by RNA polymerase II, and are polyadenylated and spliced
(ncRNA). While these RNAs do not encode proteins, they
regulate gene expression through posttranscriptional mechan-
isms (Erdmann et al., 2001b). Some of these regulatory RNAs
recognize specific nucleic acid targets through complementary
base pairing. A mechanism has been proposed for LAT to
function as an antisense to viral immediate early gene ICP0, and
LAT has been shown to inhibit the transactivating activity of
ICP0 (Farrell et al., 1991). Since the LAT does not seem to
affect the level of ICP0 mRNA, it is likely that LAT may act
posttranscriptionally. It is also interesting to note that transcripts
from ICP0 were found to be predominant in the nucleus during
the late stage of a productive infection (Ellison et al., 2000).
Whether there is any functional relationship between LAT exon
and ICP0 RNA in nucleocytoplasmic distribution, remains to be
determined.
More recently, small interfering RNA (SiRNA) and micro
RNA (miRNA) have received much attention as regulators of
gene expression (Gupta and Brewer, 2006). Interestingly several
Herpesviruses have been shown to contain these RNAs
(Murchison and Hannon, 2004; Ambros, 2004). Theoretical
predictions suggest the potential to code for several miRNAs in
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Recently, our group (Gupta et al., 2006) has demonstrated an
miRNA encoded in the LAT exon RNA. Although it remains to
be determined whether the spliced LAT exon RNA serves as the
precursor (pre-miRNA) for the miRNA, the processing of an
miRNA from the LATexon RNAmay explain its relatively short
half life. The accumulation of the LATexon RNA in the nucleus
may be explained by the fact that it is in the nucleus that miRNAs
are processed from larger RNA precursors.
Materials and methods
Cells and virus
The cells used in this study were a human neuroblastoma cell
line (SY5Y) and a human cervical epithelial cell line (HeLa).
SY5Y cells were maintained in RPMI-1640 medium (Gibco/
BRL) supplemented with 10% fetal calf serum. HeLa cells were
grown in Dulbecco's modified Eagle's medium supplement
with 5% fetal calf serum. HSV-1 strain F was used in this study.
Virus was propagated and titered on Vero cells.
Subcellular fractionation and RNA isolation
Total RNA was isolated from cell monolayers using TRIzol
reagent (Invitrogen) according to the manufacturer's protocol.
Cytoplasmic and nuclear RNAs were prepared as follows. Cell
monolayers were harvested in the Concert Cytoplasmic RNA
reagent (Invitrogen). After an initial centrifugation, the super-
natant was collected to extract cytoplasmic RNA according to
the manufacturer's instruction. The pellets were used to isolate
nuclear RNA with TRIzol reagent. For the assurance of RNA
purity, 5 μg of RNAs was denatured with glyoxal, electro-
phoresed in a 1.2% agarose gel, and then stained with acridine
orange. Visualization with a UV illuminator showed that the
nuclear rRNA precursors (32S and 45S) were exclusively
present in the nuclear RNAs while the cytoplasmic RNA
contained only mature rRNAs (18S and 28S), confirming no
detectable leakage of nuclear RNA.
Plasmids
To serve as a standard for real-time PCR assays, a plasmid
containing the LAT exon splice junction sequences was cloned
from the cDNA. Briefly, total RNA was isolated from
productively infected cells with the TRIzol reagent, treated
with DNase and then reverse-transcribed into cDNA with the
SuperScript First-strand cDNA Synthesis System (Invitrogen).Table 1
Sequences of primers and probes for real-time PCR
Gene Forward primer Rev
VP16 tgggcagcgttgataggaat gtttg
gC caacgggttaccggattacg atcc
UL15 exon junction accacgttaaaggggaaacc tggt
LAT exon junction cttcttcacccccagtaccc ctccThe region encoding the LAT exon I–exon II junction was PCR
amplified from the cDNA using primer exon 1 and exon 2N as
previously described (Krummenacher et al., 1997). The region,
which the PCR amplified, covers the 3′ of the LAT exon 1
(HSV-1 nt 119327 to nt 119464) plus 5′ end of the LAT exon II
(HSV-1 nt 121418 to nt 121526). The 245 bp PCR product was
then purified and cloned into pCR4-topo (Invitrogen) to
generate plasmid pCR4-LAT-EXJ. Similarly, a plasmid encod-
ing the exon I–exon II junction of UL15 (HSV-1 nt 29963 to
29982 plus nt 33764 to 33745) was cloned into the pCR4-topo
vector to generate plasmid pCR4-UL15-EXJ.
Plasmids were also constructed for the RNase protection
assay. To serve as the template for in vitro transcription of LAT
exon probe, the 245 bp DNA segment encoding the LAT exon
I–exon II junction was released from plasmid pCR4-LAT-EXJ
by EcoRI restriction enzyme digestion, and then inserted into
the EcoRI site of plasmids pGem7zf+ or pGem7zf− to generate
plasmids Lex1 and Lex2, respectively. To detect the 2 kb LAT
intron RNA, a 265 bp HSV segment (HSV-1 nt 119382 to nt
119647) was PCR amplified from viral DNA and cloned into
pCR4-TOPO. It was then released and cloned into the EcoRI
site of plasmids pGem7zf+ or pGem7zf−. The resulting
plasmids were named Dex1 and Dex2, respectively.
Ribonuclease protection assay (RPA)
To prepare DNA templates for in vitro transcription,
plasmids (Lex1, Lex2, Dex1, Dex2) were linearized by double
restriction enzyme digestions with NaeI and KpnI. Desired
fragments were separated via agarose gel electrophoresis,
purified by phenol–chloroform extraction, and followed by
ethanol precipitation. In vitro transcription was performed with
the Maxiscript in vitro transcription kit (Ambion). Briefly, 40
unit RNasin, 2.5 mmol of rATP, rGTP, and rUTP, 60 μmol of
rCTP, 0.2 μmol of DTT, 1× transcription buffer, 500 ng of linear
DNA template, 50 μCi of α-32P-CTP, and 20 units of T7 RNA
polymerase were mixed in a final volume of 20 μl and incubated
for 1 h at 37 °C. The reaction was terminated by adding 2 units
of DNase and incubated at 37 °C for 30 min. The product of in
vitro transcription was then loaded onto a pre-cast 6% TBE-
Urea gel (Invitrogen). Bands corresponding to the expected
sizes of labeled probes were excised and eluted into the elution
buffer at 37 °C overnight.
The RNase Protection Assay was performed with a RPAIII
kit (Ambion). Briefly, 5×105 cpm of radiolabeled probe and
various amounts of RNA, ranging from 10 μg to 40 μg were
precipitated and then resuspended with a hybridization buffer in
a final volume of 10 μl. The hybridization mixture was heated toerse primer Detection/Probe
ggggttttctcttcc (6FAM)acccgtaattgtttttcgtacgcgcg(TAMR)
ttgggtgtggcacatc (6FAM)acccgcatggagttccgcctc(TAMR)
ggacgacacgaagata SYBR green
tctgcctcttcctcct SYBR green
113W. Kang et al. / Virology 356 (2006) 106–11495 °C for 5 min before cooling down to 56 °C for an overnight
incubation. The samples were then treated with RNaseA/
RNaseT1 for 1 h at 37 °C and the reactions were terminated by
the addition of the RNase inactivation/precipitation solution.
The resulting products were precipitated at −20 °C for 30 min
and centrifuged in a microcentrifuge at the maximum speed for
15 min. The pellets which contained the protected fragments
were resuspended in a loading buffer and analyzed on a 6%
TBE-Urea gel. Following electrophoresis, gels were fixed and
dried before they were exposed to a phosphoimager screen
(Molecular Dynamics).
Quantitation of viral transcripts by RT-PCR
cDNAs were synthesized from 1 μg of DNase-treated RNA
with the superscript II preamplification kit (Invitrogen). The
manufacturer's protocol for high GC content RNA was
followed with the use of both oligo(dT) and random hexamers.
cDNAs were then amplified by real-time PCR with respective
primers in an ABI prism 7700 sequence detection system
(Applied Biosystems). To detect viral transcripts VP16 and
glycoprotein C, PCR reactions were performed with 1×
TaqMan universal PCR mix (Applied Biosystems) with
primers and probes described in Table 1. The standard curve
was generated by amplifying serial dilutions of viral DNA in
100 ng/μl mouse genomic DNA. Real-time PCR quantification
of spliced exon products of UL15 and LAT were performed in
1× SYBR green PCR mix (Applied Biosystems) with primers
shown in Table 1. The standard curve was made by
amplification of serial dilutions of plasmids encoding UL15
and LAT exon cDNA in mouse genomic DNA. For the LAT
exon qPCR assay, a slight modification to the manufacturer's
protocol was made with an increased annealing/extension
temperature at 66 °C instead of standard 60 °C. For all real-
time PCR runs with SYBR green, dissociation curve analysis
was performed to confirm the specificity of the product
amplified.
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